Charles Zhu
Stock Analyst at LifeSci Capital
(4.65)
# 885
Out of 5,133 analysts
316
Total ratings
49.2%
Success rate
14.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterated: Buy | $40 | $18.77 | +113.11% | 24 | Nov 4, 2026 | |
| ADAG Adagene | Reiterated: Buy | $8 | $1.71 | +367.84% | 12 | Oct 28, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $28 | $14.15 | +97.88% | 12 | Oct 5, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $315 | $172.29 | +82.83% | 36 | Oct 5, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $46 | $17.43 | +163.91% | 7 | Oct 3, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $34 | $26.24 | +29.57% | 30 | Sep 28, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $31.83 | +82.22% | 59 | Sep 27, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $0.7738 | - | 14 | Sep 22, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $32 | $14.02 | +128.25% | 2 | Sep 15, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $12 | $2.94 | +308.16% | 20 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $7.77 | +260.36% | 34 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $28.43 | +47.73% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $9.82 | +449.90% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $2.53 | +690.51% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.1808 | +1,006.19% | 8 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $4.31 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $25.50 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $20 | $2.20 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $28.56 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $39 | $37.09 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.251 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.93 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $20 | $1.27 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.39 | n/a | 1 | Nov 29, 2022 |
Immunome
Nov 4, 2026
Reiterated: Buy
Price Target: $40
Current: $18.77
Upside: +113.11%
Adagene
Oct 28, 2026
Reiterated: Buy
Price Target: $8
Current: $1.71
Upside: +367.84%
Crescent Biopharma
Oct 5, 2026
Reiterated: Buy
Price Target: $28
Current: $14.15
Upside: +97.88%
Revolution Medicines
Oct 5, 2026
Reiterated: Buy
Price Target: $315
Current: $172.29
Upside: +82.83%
Arcus Biosciences
Oct 3, 2026
Reiterated: Buy
Price Target: $46
Current: $17.43
Upside: +163.91%
Zymeworks
Sep 28, 2026
Reiterated: Buy
Price Target: $34
Current: $26.24
Upside: +29.57%
IDEAYA Biosciences
Sep 27, 2026
Reiterated: Buy
Price Target: $58
Current: $31.83
Upside: +82.22%
Compass Therapeutics
Sep 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.7738
Upside: -
BlossomHill Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $14.02
Upside: +128.25%
Molecular Partners AG
Aug 25, 2026
Reiterated: Buy
Price Target: $12
Current: $2.94
Upside: +308.16%
Aug 13, 2026
Reiterated: Buy
Price Target: $28
Current: $7.77
Upside: +260.36%
Aug 13, 2026
Reiterated: Buy
Price Target: $42
Current: $28.43
Upside: +47.73%
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $9.82
Upside: +449.90%
Aug 11, 2026
Rated: Buy
Price Target: $26 → $20
Current: $2.53
Upside: +690.51%
Aug 8, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $0.1808
Upside: +1,006.19%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $4.31
Upside: n/a
May 24, 2024
Reiterated: Buy
Price Target: $14
Current: $25.50
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: $12 → $20
Current: $2.20
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $28.56
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: $45 → $39
Current: $37.09
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $5
Current: $0.251
Upside: n/a
Jan 3, 2023
Reiterated: Hold
Price Target: n/a
Current: $23.93
Upside: n/a
Jan 3, 2023
Reiterated: Buy
Price Target: $30 → $20
Current: $1.27
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.39
Upside: n/a